» Authors » Raffaele Carrano

Raffaele Carrano

Explore the profile of Raffaele Carrano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 16
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Leti Maggio E, Zucca C, Grande M, Carrano R, Infante A, Bei R, et al.
J Xenobiot . 2024 Oct; 14(4):1378-1405. PMID: 39449418
Endocrine-disrupting chemicals (EDCs) are chemical substances that can interfere with any hormone action. They are categorized according to origin and use, such as industrial chemicals like polychlorinated biphenyls (PCBs) and...
2.
Focaccetti C, Nardozi D, Benvenuto M, Lucarini V, Angiolini V, Carrano R, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892447
Bisphenol-A (BPA), a synthetic compound ubiquitously present in the environment, can act as an endocrine disruptor by binding to both canonical and non-canonical estrogen receptors (ERs). Exposure to BPA has...
3.
Carrano R, Grande M, Leti Maggio E, Zucca C, Bei R, Palumbo C, et al.
Biomedicines . 2024 Mar; 12(3). PMID: 38540096
Focal adhesion plaques (FAPs) play an important role in the communication between cells and the extracellular matrix (ECM) and in cells' migration. FAPs are macromolecular complexes made by different proteins...
4.
Focaccetti C, Palumbo C, Benvenuto M, Carrano R, Melaiu O, Nardozi D, et al.
Int J Mol Sci . 2024 Jan; 25(1). PMID: 38203402
The polyphenols Curcumin (CUR) and Resveratrol (RES) are widely described for their antitumoral effects. However, their low bioavailability is a drawback for their use in therapy. The aim of this...
5.
Benvenuto M, Nardozi D, Palumbo C, Focaccetti C, Carrano R, Angiolini V, et al.
Int J Food Sci Nutr . 2023 Sep; 74(7):746-759. PMID: 37661348
Several attempts have been made to develop targeted therapies for malignant mesothelioma (MM), an aggressive tumour with a poor prognosis. In this study we evaluated whether Curcumin (CUR) potentiated the...
6.
Lucarini V, Nardozi D, Angiolini V, Benvenuto M, Focaccetti C, Carrano R, et al.
Biomedicines . 2023 Jun; 11(6). PMID: 37371856
Gastrointestinal (GI) cancers are the most frequent neoplasm, responsible for half of all cancer-related deaths. Metastasis is the leading cause of death from GI cancer; thus, studying the processes that...
7.
Benvenuto M, Angiolini V, Focaccetti C, Nardozi D, Palumbo C, Carrano R, et al.
Biol Direct . 2023 Apr; 18(1):17. PMID: 37069690
Background: Malignant mesothelioma (MM) is a rare tumor with a dismal prognosis. The low efficacy of current treatment options highlights the urge to identify more effective therapies aimed at improving...
8.
Bei R, Benvenuto M, Focaccetti C, Fazi S, Moretti M, Nardozi D, et al.
J Transl Med . 2022 Jun; 20(1):286. PMID: 35752861
Malignant mesothelioma (MM) is a rare orphan aggressive neoplasia with low survival rates. Among the other signaling pathways, ErbB receptors and Hh signaling are deregulated in MM. Thus, molecules involved...